Concepedia

Anne E.G. Lenferink

AE

34

Publications

2.2K

Citations

20

H-Index

1994

Active since

Affiliations

National Research Council Canada(Current)

Biotechnology Research Institute

Radboud University Nijmegen

National Academies of Sciences, Engineering, and Medicine

Vanderbilt University

Anne E.G. Lenferink is an author at National Research Council Canada specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1994–2023

34

Publications

34

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

Anne E.G. Lenferink · The EMBO Journal · 1998 · 407 citations · Full text

, , +10

Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

Hirokazu Kurokawa, Anne E.G. Lenferink, Jean F. Simpson et al. · PubMed · 2000 · 367 citations

, , +15

Identification of high-quality cancer prognostic markers and metastasis network modules

Jie Li, Anne E.G. Lenferink, Yinghai Deng et al. · Nature Communications · 2010 · 262 citations · Full text

ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.

Anne E.G. Lenferink, Dagmar Busse, W. Michael Flanagan et al. · PubMed · 2001 · 180 citations

, , +21

Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-α bigenic mice

Anne E.G. Lenferink, Jean F. Simpson, Laura K. Shawver et al. · Proceedings of the National Academy of Sciences · 2000 · 128 citations

Rows per page

1–5 of 34